Contributor Page
Mintz
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 617 5426000
Fax: +1 617 5422241
One Financial Center
Boston
MA 02111
United States
By Donald C. Davis
Our colleague Gil Samberg offers analysis of the U.S. Supreme Court's recent decision in Lamps Plus, Inc. v. Varela, which held that neither silence nor ambiguity in an arbitration agreement
By Jane Haviland, Laurence Freedman
The U.S. Department of Justice (DOJ) issued policy guidance on May 6, 2019, about providing credit in False Claims Act (FCA) settlements to corporations for "disclosure, cooperation, and remediation."
By Zack Navabi
In what is appears to be a former era, prior to the travel ban, the nuclear deal, and the hostage crisis, the United States encouraged travel from Iran to "promote further mutual understanding of peoples."
By Adam Samansky, Peter Cuomo, Joseph Rutkowski
On April 17, 2019, Judge Gilstrap of the United States District Court for the Eastern District of Texas, in Apicore v. Beloteca, No. 19-cv-00077, held that while the court
By Alison G. Renner
In a recent post, we discussed the U.S. Department of Labor's (DOL) proposed rule increasing the salary threshold to qualify for a white collar exemption under federal law.
By Donald C. Davis
Yesterday, the United States Supreme Court decided that it will hear three cases in its next term, which, taken together
By Donald C. Davis
District employers, get on your marks! We told you way back in 2017 that Universal Paid Leave (UPL) would be coming to the District,
By Donald C. Davis
We recently provided DC employers with information about the imminent Universal Paid Leave tax. Since that post, we have received word from the DC Office of Employment Services (DOES)
By Alain P. Mathieu, Joel Rothman
In the Traffic Monsoon litigation, the U.S. Court of Appeals for the Tenth Circuit held that the enforcement provisions of the Securities Act and the Exchange Act reach Traffic Monsoon's sales
By Verna Krishnamurthy
The Impact Terms Project ("ITP") was launched as a platform intended to provide guidance on best practices to entrepreneurs, investors and other stakeholders in the rapidly-evolving social enterprise space.
By Alexander Hecht, Frank C. Guinta, Aaron L. Josephson, Kate F. Josephson, Eli Greenspan
Welcome back. This week will focus largely on "Medicare for All" proposals. The House Rules Committee will hold the first hearing on the subject this Congress
By Joanne Hawana, Elizabeth K. Conti
Since our 2018 year-end post on the busy FDA regulatory agenda, we are nearing the halfway mark of the "grace period" the Agency has extended for certain regenerative medicine product developers to
By Samantha Kingsbury
As many of our readers know, we have been closely following the Polukoff False Claims Act (FCA) qui tam case in the Tenth Circuit for the lessons it might offer in defending FCA cases premised on
By David A. Chorney
As predicted by our colleagues earlier this month, outgoing Commissioner Scott Gottlieb of the U.S. Food and Drug Administration (FDA) released a comprehensive press release.
By Benjamin Zegarelli, Aaron L. Josephson
Regulation of cannabidiol (CBD) was a hot topic on Day 1 of ACI's Cosmetics & Personal Care Products conference on March 28, 2019.
Contributor's Topics
More...